GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the 2.4mg rule is doing its job and people should stop complaining — 47 comments in the full submission. View in context.
3k
c/semaglutide·submitted 1 year ago by u/pavel_nkemelu

[Meta] the 2.4mg rule is doing its job and people should stop complaining

Metabranch of 6 comments

the 2.4mg rule is doing its job and people should stop complaining, and it will stay as it is unless somebody makes the case to change it. The numbers the title promised, since a headline without them is worthless: 2.4mg. Everything below is context for those. Research-use-only material is not approved for human use,…

Read the full submission and all 47 comments →

This branch

6 comments, started 1 year ago
u/sofia_wikstrom352 points·1 year ago

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

replysharereportpermalink
u/nikhil_teixeira0 points·1 year ago

Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.

replysharereportpermalink
u/prior_auth_painappeals290 points·1 year ago

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg.

sofia_wikstrom is describing the standard shape here and it matches the trial data better than most anecdotes do.

replysharereportpermalink
u/zofia_lindholm69 points·1 year ago

the scale is the least sensitive instrument you own

replysharereportpermalink
u/arne_amankwah78 points·1 year ago

How long was the stall before you decided it was a stall?

replysharereportpermalink
u/kaplan_meier_kim54 points·1 year ago

How long was the stall before you decided it was a stall?

Disagree with this specific line. A pause at 1.7mg is not evidence that 1.7mg has stopped working.

replysharereportpermalink

← back to the whole thread

About c/semaglutide

Everything semaglutide: branded pens, compounded vials, oral formulations and the research-grade material people reconstitute themselves. Titration schedules, side-effect management, plateau troubleshooting and long-term maintenance. Dose questions are welcome; "what dose should I take" answers are not, because nobody here is your prescriber.

215kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/semaglutide rules
  1. No requests for a personal dose recommendation — describe what you did, not what someone else should do.
  2. Results posts need a timeframe and a starting point, or they get removed as unverifiable.
  3. Brand, compounded and research-grade material are all on-topic. Sourcing requests are not — that is c/vendorvetting.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.